BDKRB1 and type 2 diabetes mellitus: Similarly, 1-week treatment with the B1R antagonist SSR240612 reduced whole body and epididymal fat mass in high glucose feeding rats [16], supporting a role for B1R in obesity associated with type 2 diabetes.